Women's Health

In a recent study, researchers sought to determine the potential for the overdiagnosis of breast cancer after screening for women 70 years of age and older.

Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.

In a post hoc analysis of two phase 3 trials, researchers set out to determine the impact of sex on tofacitinib in terms of efficacy, safety, and time to discontinuation.

Researchers evaluated the mortality risk of patients with polycystic ovarian syndrome and the risk of death associated with disease comorbidities.

The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.

The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.

A team of researchers determined the impact of obstructive sleep apnea and insomnia on cognitive decline in women with multiple sclerosis.

The US Preventive Services Task Force (USPSTF) issued a draft recommendation regarding breast cancer screening in women aged 40 years old to 74 years old.

Researchers aimed to longitudinally examine both the variability of musculoskeletal pain among individuals with breast cancer and any potential predictors for pain during the first 18 months of aromatase...